4//SEC Filing
Hanrahan Jessie 4
Accession 0000950170-24-133369
CIK 0001707502other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:34 PM ET
Size
8.7 KB
Accession
0000950170-24-133369
Insider Transaction Report
Form 4
Hanrahan Jessie
Chief Regulatory Officer
Transactions
- Sale
Common Stock
2024-12-03$5.60/sh−4,610$25,822→ 14,235 total - Exercise/Conversion
Common Stock
2024-12-02+11,862→ 18,845 total - Exercise/Conversion
Restricted Stock Units
2024-12-02−11,862→ 23,725 total→ Common Stock (11,862 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs. The sale does not represent a discretionary trade made by Dr. Hanrahan.
- [F3]The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001954826
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:34 PM ET
- Size
- 8.7 KB